KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Common Equity (2016 - 2026)

Staar Surgical (STAA) has disclosed Common Equity for 17 consecutive years, with $344.2 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Common Equity fell 13.38% year-over-year to $344.2 million, compared with a TTM value of $344.2 million through Jan 2026, down 13.38%, and an annual FY2026 reading of $344.2 million, down 13.38% over the prior year.
  • Common Equity was $344.2 million for Q1 2026 at Staar Surgical, down from $353.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $428.1 million in Q3 2024 and bottomed at $276.3 million in Q2 2022.
  • Average Common Equity over 5 years is $357.2 million, with a median of $351.9 million recorded in 2025.
  • The sharpest move saw Common Equity rose 29.72% in 2022, then fell 17.73% in 2025.
  • Year by year, Common Equity stood at $336.1 million in 2022, then rose by 14.83% to $386.0 million in 2023, then rose by 2.95% to $397.3 million in 2024, then dropped by 10.96% to $353.8 million in 2025, then decreased by 2.71% to $344.2 million in 2026.
  • Business Quant data shows Common Equity for STAA at $344.2 million in Q1 2026, $353.8 million in Q3 2025, and $336.6 million in Q2 2025.